Multispecific deimmunized CD3-binders

Details for Australian Patent Application No. 2004283850 (hide)

International Classifications

Event Publications

30 March 2006 PCT application entered the National Phase

PCT publication WO2005/040220 Priority application(s): WO2005/040220

7 April 2011 Application Accepted

Published as AU-B-2004283850

14 July 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 16 Jun 2011. Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000 2005

3 November 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 16 Jun 2011 2005

10 November 2011 Standard Patent Sealed

20 September 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.